Delivery Order SPE2DE24D0013-SPE2D626F6122

Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain on October 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for respiratory diagnostic testing supplies and is scheduled for completion by November 12, 2025. This award represents part of Cepheid's extensive federal supplier relationship, through which the company provides diagnostic reagents, test kits, and molecular testing systems to support infectious disease detection capabilities across multiple federal healthcare agencies. The contract utilizes no set-aside designation, reflecting Cepheid's competitive positioning in the federal diagnostics procurement marketplace.

This delivery order falls within the context of Cepheid's broader role as a critical supplier of point-of-care molecular diagnostic solutions to federal health systems. The company has established itself as a primary vendor to the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and Defense Logistics Agency, with particular expertise in GeneXpert platform diagnostics for detecting COVID-19, influenza, respiratory syncytial virus, and other infectious pathogens. Cepheid maintains significant Indefinite Delivery Contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030, which provides the framework for sustained procurement of diagnostic reagents and testing supplies across the federal healthcare system.